Skip to main content

Table 1 Reported outcomes, types of participants and follow ups

From: Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis

Trials

Outcomes

Follow-up periods

Types of participants

INFUSE AMI [11]

All-cause death, MACEs, definite and probable ST, HORIZONS major bleeding

30 days and 1 year

STEMI undergoing PCI

JUMBO TIMI 26 [12]

Non-CABG TIMI major and minor bleeding, minimal bleeding, MACEs, all-cause death, stroke, MI, recurrent ischemia, ST

30 days

Elective or urgent PCI

PRASFIT ACS [13]

MACEs, all-cause death, CV death, ST, revascularization, MI, stroke, TIMI defined minor and major bleeding

6 months, 1 year

ACS undergoing PCI

PRINCIPLE TIMI 44 [14]

TIMI major and minor bleeding, overall bleeding events, ST, MI, MACEs

1 month

Elective PCI

TAILOR [15]

MACEs, MI, stroke, ST, CV death

1 month, 1.5 years

Elective PCI

TRANSLATE ACS [16]

All-cause death, MI, stroke, revascularization, MACEs, BARC bleeding type 1–5, GUSTO moderate/severe bleeding

6 months

ACS undergoing PCI

TRIGGER PCI [17]

MACEs, CV death, MI, definite and probable ST, all-cause death, TIMI major bleeding

8 months

Elective PCI

TRITON TIMI 38 [18]

MACEs, CV death, all-cause death, MI, stroke, revascularization, ST, TIMI major or minor bleeding

15 months

STEMI undergoing PCI

  1. Abbreviations: MACEs major adverse cardiac events, HORIZONS Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction, CABG coronary artery bypass grafting, TIMI thrombolysis in myocardial infarction, ST stent thrombosis, CV cardiovascular, MI myocardial infarction, GUSTO Global Use of Strategies to Open Occluded Arteries, BARC bleeding defined according to the academic research consortium, STEMI ST elevated myocardial infarction, PCI percutaneous coronary intervention, ACS acute coronary syndrome, CAD coronary artery disease, T2DM type 2 diabetes mellitus